Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0609|100|3|294-303

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.100, Iss.3, 2018-03, pp. : 294-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Abstract

BackgroundMedicines that exert oxidative pressure on red blood cells (RBC) can cause severe hemolysis in patients with glucose‐6‐phosphate dehydrogenase (G6PD) deficiency. Due to X‐chromosome inactivation, females heterozygous for G6PD with 1 allele encoding a G6PD‐deficient protein and the other a normal protein produce 2 RBC populations each expressing exclusively 1 allele. The G6PD mosaic is not captured with routine G6PD tests.
MethodsAn open‐source software tool for G6PD cytofluorometric data interpretation is described. The tool interprets data in terms of % bright RBC, or cells with normal G6PD activity in specimens collected from 2 geographically and ethnically distinct populations, an African American cohort (USA) and a Karen and Burman ethnic cohort (Thailand) comprising 242 specimens including 89 heterozygous females.
ResultsThe tool allowed comparison of data across 2 laboratories and both populations. Hemizygous normal or deficient males and homozygous normal or deficient females cluster at narrow % bright cells with mean values of 96%, or 6% (males) and 97%, or 2% (females), respectively. Heterozygous females show a distribution of 10‐85% bright cells and a mean of 50%. The distributions are associated with the severity of the G6PD mutation.
ConclusionsConsistent cytofluorometric G6PD analysis facilitates interlaboratory comparison of cellular G6PD profiles and contributes to understanding primaquine‐associated hemolytic risk.

Related content

Rasburicase‐induced methaemoglobinaemia and G6PD deficiency in an unusual suspect

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 5, 2015-09 ,pp. : 595-595 (1)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency in Greek newborns: The Mediterranean C563T mutation screening

By Molou Elina   Schulpis Kleopatra H.   Thodi Georgia   Georgiou Vassiliki   Dotsikas Yannis   Papadopoulos Konstantinos   Biti Sofia   Loukas Yannis L.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 74, Iss. 3, 2014-04 ,pp. : 259-263 (5)

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 2, 2014-08 ,pp. : 169-174 (6)

John Wiley & Sons Inc

Access to resources Recommend Favorite

EP21.21: Fetal anemia caused by the Guadalajara variant of G6PD deficiency

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 48, Iss. S1, 2016-09 ,pp. : 362-362 (1)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Life and Death of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Erythrocytes – Role of Redox Stress and Band 3 Modifications

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 5, 2012-09 ,pp. : 328-334 (7)

Karger

Access to resources Recommend Favorite